Tg Therapeutics (TGTX) Inventory Average (2023 - 2025)
Historic Inventory Average for Tg Therapeutics (TGTX) over the last 3 years, with Q3 2025 value amounting to $151.1 million.
- Tg Therapeutics' Inventory Average rose 8211.76% to $151.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.1 million, marking a year-over-year increase of 8211.76%. This contributed to the annual value of $75.1 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Tg Therapeutics reported Inventory Average of $151.1 million as of Q3 2025, which was up 8211.76% from $156.5 million recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Inventory Average peaked at $156.5 million during Q2 2025, and registered a low of $28.7 million during Q2 2023.
- In the last 3 years, Tg Therapeutics' Inventory Average had a median value of $81.2 million in 2024 and averaged $85.8 million.
- Per our database at Business Quant, Tg Therapeutics' Inventory Average soared by 17667.22% in 2024 and then soared by 8211.76% in 2025.
- Over the past 3 years, Tg Therapeutics' Inventory Average (Quarter) stood at $36.7 million in 2023, then skyrocketed by 165.93% to $97.6 million in 2024, then surged by 54.85% to $151.1 million in 2025.
- Its Inventory Average stands at $151.1 million for Q3 2025, versus $156.5 million for Q2 2025 and $134.1 million for Q1 2025.